Cargando…
Rett syndrome: a neurological disorder with metabolic components
Rett syndrome (RTT) is a neurological disorder caused by mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2), a ubiquitously expressed transcriptional regulator. Despite remarkable scientific progress since its discovery, the mechanism by which MECP2 mutations cause RTT symptoms is l...
Autores principales: | Kyle, Stephanie M., Vashi, Neeti, Justice, Monica J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830535/ https://www.ncbi.nlm.nih.gov/pubmed/29445033 http://dx.doi.org/10.1098/rsob.170216 |
Ejemplares similares
-
Treating Rett syndrome: from mouse models to human therapies
por: Vashi, Neeti, et al.
Publicado: (2019) -
Aberrant lung lipids cause respiratory impairment in a Mecp2-deficient mouse model of Rett syndrome
por: Vashi, Neeti, et al.
Publicado: (2021) -
A suppressor screen in mouse Mecp2 implicates cholesterol metabolism in Rett Syndrome
por: Buchovecky, Christie M., et al.
Publicado: (2013) -
Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review
por: Tascini, Giorgia, et al.
Publicado: (2022) -
Sphingolipid Metabolism Perturbations in Rett Syndrome
por: Cappuccio, Gerarda, et al.
Publicado: (2019)